Examining the immunoreactivities of the receptor-binding domain of SARS-CoV-2 spike proteins using a panel of human monoclonal antibodies
Previously, a panel of human monoclonal antibodies (hMAbs) (PD5, SC23, and PD4) were isolated from convalescent patients to evaluate their therapeutic potential in the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the binding domains of these antibodies have not been...
Saved in:
Main Author: | Tan, Jie Ling |
---|---|
Other Authors: | Richard J Sugrue |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/157131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Development of human monoclonal antibodies against SARS-CoV-2
by: Wong, Joel Xu En
Published: (2021) -
Interaction of SARS-CoV spike protein with lipid rafts of host cells during viral entry
by: Lu, Yanning
Published: (2008) -
Development of SARS-COV therapeutics using quaternary protein mimetics
by: Neo, Tuan Ling
Published: (2010) -
Study of sars-cov entry mechanism and development of protein mimetic inhibitors
by: Ji, Zhe
Published: (2011) -
Characterization of monoclonal antibody specificities against conformational epitopes of dengue NS1 glycoprotein.
by: Cheng, Wei.
Published: (2009)